您的位置: 首页 > 农业专利 > 详情页

Formulations of (S) - 3 - (4 - ((4 - (morfolinometil) benzyl) oxy) - 1 - oxoisoindolin - 2 - il) piperidin 2.6 - dione
专利权人:
CELGENE CORPORATION
发明人:
DARSHAN, PARIKH,ANIL, MENON
申请号:
TR201905874
公开号:
TR201905874T4
申请日:
2014.10.07
申请国别(地区):
TR
年份:
2019
代理人:
摘要:
Refers to a Pharmaceutical composition comprising: (S) - 3 - (4 - ((4 - (morfolinometil) benzyl) oxy) - 1 - oxoisoindolin - 2 - il) piperidin 2.6 - dione, also called CC - 220, or a pharmaceutically acceptable Salt, solvate, hydrate, clathrate, stereoisomer, tautomero or Racemic mixtures of the same, A number of 0.1 to 3% of the total weight of the Dosing and a component in an amount of 90 to 99.9% by weight of the total weight of the dosage form, where the component is Starch, lactose or a mixture of them. Useful for treating or Preventing diseases such as cancer, inflammatory disease and / or disease related to the immune system.Farmasötik bileşimler ve (S)-3-(4-((4-(morfolinometil)benzil)oksi)-1-oksoizoindolin-2-il)piperidin-2,6-dionun tek birim doz formları veya farmasötik olarak kabul edilen bir stereoizomer, ön ilaç, tuz, solvat, hidrat veya klatrat burada sağlanmaktadır. Ayrıca kanser, inflamatuvar hastalık ve/veya bağışıklıkla ilgili bozukluğun tedavi, yönetim, veya önlenme yöntemleri sağlanmaktadır.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充